SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Madharry who wrote (1167)1/16/2001 11:49:21 PM
From: wolfdog2  Read Replies (1) of 1386
 
Madharry, if approval is needed it would be gotten from the next of kin.

As to the big pharmas, I think it is pretty clear that PARS wants to go it a alone as far as they can. A drug can be partnered much more successfully after rather than before completion of P3. Also note that the market for TBI is large for PARS but on the smallish side for a major pharma.

I detect a note of sarcasm in your post. (I'd have to be unconscious not to.) I suggest that you listen to the JPM HQ presentation by PARS.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News